Industry Research Reports

Home > Reports > Chemical & Material > Simvastatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Simvastatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-06-16

Pages: 151 Pages

Report ld: 6784576

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Simvastatin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Simvastatin API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Simvastatin(CAS：79902-63-9) is a statin, a type of lipid-lowering medication.It is used along with exercise, diet, and weight loss to decrease elevated lipid levels.It is also used to decrease the risk of heart problems in those at high risk.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Simvastatin API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Simvastatin API market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Simvastatin API.

MARKET SEGMENTATION

By Company

Sun Pharma
Teva
Otto Brandes
Rochem International Inc
NEWEDGE Overseas
Sterling Biotech Limited
Kyongbo Pharmaceutical Co., Ltd
HELM Portugal
HELM Portugal
Ipca Laboratories
HEC Pharm
Zhejiang Hisun Pharmaceutical
Southwest Synthetic Pharmaceutical
Krebs Biochemicals & Industries Ltd
Biocon
Zhejiang Jingxin Pharmaceutical
Hetero Drugs
DEAFARMA
Tecoland Corporation

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Simvastatin API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Simvastatin API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Simvastatin API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Simvastatin API Product Introduction

1.2 Global Simvastatin API Market Size Forecast

1.2.1 Global Simvastatin API Sales Value (2021–2032)

1.2.2 Global Simvastatin API Sales Volume (2021–2032)

1.2.3 Global Simvastatin API Sales Price (2021–2032)

1.3 Simvastatin API Market Trends & Drivers

1.3.1 Simvastatin API Industry Trends

1.3.2 Simvastatin API Market Drivers & Opportunities

1.3.3 Simvastatin API Market Challenges

1.3.4 Simvastatin API Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Simvastatin API Players Revenue Ranking (2025)

2.2 Global Simvastatin API Revenue by Company (2021–2026)

2.3 Global Simvastatin API Sales Volume Ranking of Players (2025)

2.4 Global Simvastatin API Sales Volume by Company (2021–2026)

2.5 Global Simvastatin API Average Price by Company (2021–2026)

2.6 Key Manufacturers Simvastatin API Manufacturing Base and Headquarters

2.7 Key Manufacturers Simvastatin API Product Offerings

2.8 Key Manufacturers Start of Mass Production of Simvastatin API

2.9 Simvastatin API Market Competitive Analysis

2.9.1 Simvastatin API Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Simvastatin API Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Simvastatin API revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Simvastatin API Market Classification

3.1 Introduction by Type

3.1.1 Above 98 %

3.1.2 Above 99 %

3.1.3 Global Simvastatin API Sales Value by Type

3.1.3.1 Global Simvastatin API Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Simvastatin API Sales Value, by Type (2021–2032)

3.1.3.3 Global Simvastatin API Sales Value, by Type (%), 2021–2032

3.1.4 Global Simvastatin API Sales Volume by Type

3.1.4.1 Global Simvastatin API Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Simvastatin API Sales Volume, by Type (2021–2032)

3.1.4.3 Global Simvastatin API Sales Volume, by Type (%), 2021–2032

3.1.5 Global Simvastatin API Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Others

4.2 Global Simvastatin API Sales Value by Application

4.2.1 Global Simvastatin API Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Simvastatin API Sales Value, by Application (2021–2032)

4.2.3 Global Simvastatin API Sales Value, by Application (%), 2021–2032

4.3 Global Simvastatin API Sales Volume by Application

4.3.1 Global Simvastatin API Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Simvastatin API Sales Volume, by Application (2021–2032)

4.3.3 Global Simvastatin API Sales Volume, by Application (%), 2021–2032

4.4 Global Simvastatin API Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Simvastatin API Sales Value by Region

5.1.1 Global Simvastatin API Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Simvastatin API Sales Value by Region (2021–2026)

5.1.3 Global Simvastatin API Sales Value by Region (2027–2032)

5.1.4 Global Simvastatin API Sales Value by Region (%), 2021–2032

5.2 Global Simvastatin API Sales Volume by Region

5.2.1 Global Simvastatin API Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Simvastatin API Sales Volume by Region (2021–2026)

5.2.3 Global Simvastatin API Sales Volume by Region (2027–2032)

5.2.4 Global Simvastatin API Sales Volume by Region (%), 2021–2032

5.3 Global Simvastatin API Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Simvastatin API Sales Value, 2021–2032

5.4.2 North America Simvastatin API Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Simvastatin API Sales Value, 2021–2032

5.5.2 Europe Simvastatin API Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Simvastatin API Sales Value, 2021–2032

5.6.2 Asia Pacific Simvastatin API Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Simvastatin API Sales Value, 2021–2032

5.7.2 South America Simvastatin API Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Simvastatin API Sales Value, 2021–2032

5.8.2 Middle East & Africa Simvastatin API Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Simvastatin API Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Simvastatin API Sales Value and Sales Volume

6.2.1 Key Countries/Regions Simvastatin API Sales Value, 2021–2032

6.2.2 Key Countries/Regions Simvastatin API Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Simvastatin API Sales Value, 2021–2032

6.3.2 United States Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Simvastatin API Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Simvastatin API Sales Value, 2021–2032

6.4.2 Europe Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Simvastatin API Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Simvastatin API Sales Value, 2021–2032

6.5.2 China Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.5.3 China Simvastatin API Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Simvastatin API Sales Value, 2021–2032

6.6.2 Japan Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Simvastatin API Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Simvastatin API Sales Value, 2021–2032

6.7.2 South Korea Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Simvastatin API Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Simvastatin API Sales Value, 2021–2032

6.8.2 Southeast Asia Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Simvastatin API Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Simvastatin API Sales Value, 2021–2032

6.9.2 India Simvastatin API Sales Value by Type (%), 2025 vs 2032

6.9.3 India Simvastatin API Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Sun Pharma

7.1.1 Sun Pharma Company Information

7.1.2 Sun Pharma Introduction and Business Overview

7.1.3 Sun Pharma Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Sun Pharma Simvastatin API Product Offerings

7.1.5 Sun Pharma Recent Developments

7.2 Teva

7.2.1 Teva Company Information

7.2.2 Teva Introduction and Business Overview

7.2.3 Teva Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Teva Simvastatin API Product Offerings

7.2.5 Teva Recent Developments

7.3 Otto Brandes

7.3.1 Otto Brandes Company Information

7.3.2 Otto Brandes Introduction and Business Overview

7.3.3 Otto Brandes Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Otto Brandes Simvastatin API Product Offerings

7.3.5 Otto Brandes Recent Developments

7.4 Rochem International Inc

7.4.1 Rochem International Inc Company Information

7.4.2 Rochem International Inc Introduction and Business Overview

7.4.3 Rochem International Inc Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Rochem International Inc Simvastatin API Product Offerings

7.4.5 Rochem International Inc Recent Developments

7.5 NEWEDGE Overseas

7.5.1 NEWEDGE Overseas Company Information

7.5.2 NEWEDGE Overseas Introduction and Business Overview

7.5.3 NEWEDGE Overseas Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 NEWEDGE Overseas Simvastatin API Product Offerings

7.5.5 NEWEDGE Overseas Recent Developments

7.6 Sterling Biotech Limited

7.6.1 Sterling Biotech Limited Company Information

7.6.2 Sterling Biotech Limited Introduction and Business Overview

7.6.3 Sterling Biotech Limited Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Sterling Biotech Limited Simvastatin API Product Offerings

7.6.5 Sterling Biotech Limited Recent Developments

7.7 Kyongbo Pharmaceutical Co., Ltd

7.7.1 Kyongbo Pharmaceutical Co., Ltd Company Information

7.7.2 Kyongbo Pharmaceutical Co., Ltd Introduction and Business Overview

7.7.3 Kyongbo Pharmaceutical Co., Ltd Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Kyongbo Pharmaceutical Co., Ltd Simvastatin API Product Offerings

7.7.5 Kyongbo Pharmaceutical Co., Ltd Recent Developments

7.8 HELM Portugal

7.8.1 HELM Portugal Company Information

7.8.2 HELM Portugal Introduction and Business Overview

7.8.3 HELM Portugal Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 HELM Portugal Simvastatin API Product Offerings

7.8.5 HELM Portugal Recent Developments

7.9 HELM Portugal

7.9.1 HELM Portugal Company Information

7.9.2 HELM Portugal Introduction and Business Overview

7.9.3 HELM Portugal Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 HELM Portugal Simvastatin API Product Offerings

7.9.5 HELM Portugal Recent Developments

7.10 Ipca Laboratories

7.10.1 Ipca Laboratories Company Information

7.10.2 Ipca Laboratories Introduction and Business Overview

7.10.3 Ipca Laboratories Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Ipca Laboratories Simvastatin API Product Offerings

7.10.5 Ipca Laboratories Recent Developments

7.11 HEC Pharm

7.11.1 HEC Pharm Company Information

7.11.2 HEC Pharm Introduction and Business Overview

7.11.3 HEC Pharm Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 HEC Pharm Simvastatin API Product Offerings

7.11.5 HEC Pharm Recent Developments

7.12 Zhejiang Hisun Pharmaceutical

7.12.1 Zhejiang Hisun Pharmaceutical Company Information

7.12.2 Zhejiang Hisun Pharmaceutical Introduction and Business Overview

7.12.3 Zhejiang Hisun Pharmaceutical Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.12.4 Zhejiang Hisun Pharmaceutical Simvastatin API Product Offerings

7.12.5 Zhejiang Hisun Pharmaceutical Recent Developments

7.13 Southwest Synthetic Pharmaceutical

7.13.1 Southwest Synthetic Pharmaceutical Company Information

7.13.2 Southwest Synthetic Pharmaceutical Introduction and Business Overview

7.13.3 Southwest Synthetic Pharmaceutical Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.13.4 Southwest Synthetic Pharmaceutical Simvastatin API Product Offerings

7.13.5 Southwest Synthetic Pharmaceutical Recent Developments

7.14 Krebs Biochemicals & Industries Ltd

7.14.1 Krebs Biochemicals & Industries Ltd Company Information

7.14.2 Krebs Biochemicals & Industries Ltd Introduction and Business Overview

7.14.3 Krebs Biochemicals & Industries Ltd Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.14.4 Krebs Biochemicals & Industries Ltd Simvastatin API Product Offerings

7.14.5 Krebs Biochemicals & Industries Ltd Recent Developments

7.15 Biocon

7.15.1 Biocon Company Information

7.15.2 Biocon Introduction and Business Overview

7.15.3 Biocon Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.15.4 Biocon Simvastatin API Product Offerings

7.15.5 Biocon Recent Developments

7.16 Zhejiang Jingxin Pharmaceutical

7.16.1 Zhejiang Jingxin Pharmaceutical Company Information

7.16.2 Zhejiang Jingxin Pharmaceutical Introduction and Business Overview

7.16.3 Zhejiang Jingxin Pharmaceutical Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.16.4 Zhejiang Jingxin Pharmaceutical Simvastatin API Product Offerings

7.16.5 Zhejiang Jingxin Pharmaceutical Recent Developments

7.17 Hetero Drugs

7.17.1 Hetero Drugs Company Information

7.17.2 Hetero Drugs Introduction and Business Overview

7.17.3 Hetero Drugs Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.17.4 Hetero Drugs Simvastatin API Product Offerings

7.17.5 Hetero Drugs Recent Developments

7.18 DEAFARMA

7.18.1 DEAFARMA Company Information

7.18.2 DEAFARMA Introduction and Business Overview

7.18.3 DEAFARMA Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.18.4 DEAFARMA Simvastatin API Product Offerings

7.18.5 DEAFARMA Recent Developments

7.19 Tecoland Corporation

7.19.1 Tecoland Corporation Company Information

7.19.2 Tecoland Corporation Introduction and Business Overview

7.19.3 Tecoland Corporation Simvastatin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.19.4 Tecoland Corporation Simvastatin API Product Offerings

7.19.5 Tecoland Corporation Recent Developments

8 Industry Chain Analysis

8.1 Simvastatin API Industrial Chain

8.2 Simvastatin API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Simvastatin API Sales Model

8.5.2 Sales Channels

8.5.3 Simvastatin API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Simvastatin API Market Trends

Table 2. Simvastatin API Market Drivers & Opportunities

Table 3. Simvastatin API Market Challenges

Table 4. Simvastatin API Market Restraints

Table 5. Global Simvastatin API Revenue by Company (US$ Million), 2021–2026

Table 6. Global Simvastatin API Revenue Market Share by Company (2021–2026)

Table 7. Global Simvastatin API Sales Volume by Company (Kg), 2021–2026

Table 8. Global Simvastatin API Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Simvastatin API Price by Company (US$/Kg), 2021–2026

Table 10. Key Manufacturers Simvastatin API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Simvastatin API Product Type

Table 12. Key Manufacturers Start of Mass Production of Simvastatin API

Table 13. Global Simvastatin API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Simvastatin API revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Simvastatin API Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Simvastatin API Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Simvastatin API Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Simvastatin API Sales Market Share in Value by Type (2021–2026)

Table 20. Global Simvastatin API Sales Market Share in Value by Type (2027–2032)

Table 21. Global Simvastatin API Sales Volume by Type: 2021 vs 2025 vs 2032 (Kg)

Table 22. Global Simvastatin API Sales Volume by Type (Kg), 2021–2026

Table 23. Global Simvastatin API Sales Volume by Type (Kg), 2027–2032

Table 24. Global Simvastatin API Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Simvastatin API Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Simvastatin API Price by Type (US$/Kg), 2021–2026

Table 27. Global Simvastatin API Price by Type (US$/Kg), 2027–2032

Table 28. Global Simvastatin API Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Simvastatin API Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Simvastatin API Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Simvastatin API Sales Market Share in Value by Application (2021–2026)

Table 32. Global Simvastatin API Sales Market Share in Value by Application (2027–2032)

Table 33. Global Simvastatin API Sales Volume by Application: 2021 vs 2025 vs 2032 (Kg)

Table 34. Global Simvastatin API Sales Volume by Application (Kg), 2021–2026

Table 35. Global Simvastatin API Sales Volume by Application (Kg), 2027–2032

Table 36. Global Simvastatin API Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Simvastatin API Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Simvastatin API Price by Application (US$/Kg), 2021–2026

Table 39. Global Simvastatin API Price by Application (US$/Kg), 2027–2032

Table 40. Global Simvastatin API Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Simvastatin API Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Simvastatin API Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Simvastatin API Sales Value by Region (%), 2021–2026

Table 44. Global Simvastatin API Sales Value by Region (%), 2027–2032

Table 45. Global Simvastatin API Sales Volume by Region (Kg): 2021 vs 2025 vs 2032

Table 46. Global Simvastatin API Sales Volume by Region (Kg), 2021–2026

Table 47. Global Simvastatin API Sales Volume by Region (Kg), 2027–2032

Table 48. Global Simvastatin API Sales Volume by Region (%), 2021–2026

Table 49. Global Simvastatin API Sales Volume by Region (%), 2027–2032

Table 50. Global Simvastatin API Average Price by Region (US$/Kg), 2021–2026

Table 51. Global Simvastatin API Average Price by Region (US$/Kg), 2027–2032

Table 52. Key Countries/Regions Simvastatin API Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Simvastatin API Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Simvastatin API Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Simvastatin API Sales Volume, (Kg), 2021–2026

Table 56. Key Countries/Regions Simvastatin API Sales Volume, (Kg), 2027–2032

Table 57. Sun Pharma Company Information

Table 58. Sun Pharma Introduction and Business Overview

Table 59. Sun Pharma Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 60. Sun Pharma Simvastatin API Product Offerings

Table 61. Sun Pharma Recent Developments

Table 62. Teva Company Information

Table 63. Teva Introduction and Business Overview

Table 64. Teva Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 65. Teva Simvastatin API Product Offerings

Table 66. Teva Recent Developments

Table 67. Otto Brandes Company Information

Table 68. Otto Brandes Introduction and Business Overview

Table 69. Otto Brandes Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 70. Otto Brandes Simvastatin API Product Offerings

Table 71. Otto Brandes Recent Developments

Table 72. Rochem International Inc Company Information

Table 73. Rochem International Inc Introduction and Business Overview

Table 74. Rochem International Inc Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 75. Rochem International Inc Simvastatin API Product Offerings

Table 76. Rochem International Inc Recent Developments

Table 77. NEWEDGE Overseas Company Information

Table 78. NEWEDGE Overseas Introduction and Business Overview

Table 79. NEWEDGE Overseas Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 80. NEWEDGE Overseas Simvastatin API Product Offerings

Table 81. NEWEDGE Overseas Recent Developments

Table 82. Sterling Biotech Limited Company Information

Table 83. Sterling Biotech Limited Introduction and Business Overview

Table 84. Sterling Biotech Limited Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 85. Sterling Biotech Limited Simvastatin API Product Offerings

Table 86. Sterling Biotech Limited Recent Developments

Table 87. Kyongbo Pharmaceutical Co., Ltd Company Information

Table 88. Kyongbo Pharmaceutical Co., Ltd Introduction and Business Overview

Table 89. Kyongbo Pharmaceutical Co., Ltd Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 90. Kyongbo Pharmaceutical Co., Ltd Simvastatin API Product Offerings

Table 91. Kyongbo Pharmaceutical Co., Ltd Recent Developments

Table 92. HELM Portugal Company Information

Table 93. HELM Portugal Introduction and Business Overview

Table 94. HELM Portugal Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 95. HELM Portugal Simvastatin API Product Offerings

Table 96. HELM Portugal Recent Developments

Table 97. HELM Portugal Company Information

Table 98. HELM Portugal Introduction and Business Overview

Table 99. HELM Portugal Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 100. HELM Portugal Simvastatin API Product Offerings

Table 101. HELM Portugal Recent Developments

Table 102. Ipca Laboratories Company Information

Table 103. Ipca Laboratories Introduction and Business Overview

Table 104. Ipca Laboratories Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 105. Ipca Laboratories Simvastatin API Product Offerings

Table 106. Ipca Laboratories Recent Developments

Table 107. HEC Pharm Company Information

Table 108. HEC Pharm Introduction and Business Overview

Table 109. HEC Pharm Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 110. HEC Pharm Simvastatin API Product Offerings

Table 111. HEC Pharm Recent Developments

Table 112. Zhejiang Hisun Pharmaceutical Company Information

Table 113. Zhejiang Hisun Pharmaceutical Introduction and Business Overview

Table 114. Zhejiang Hisun Pharmaceutical Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 115. Zhejiang Hisun Pharmaceutical Simvastatin API Product Offerings

Table 116. Zhejiang Hisun Pharmaceutical Recent Developments

Table 117. Southwest Synthetic Pharmaceutical Company Information

Table 118. Southwest Synthetic Pharmaceutical Introduction and Business Overview

Table 119. Southwest Synthetic Pharmaceutical Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 120. Southwest Synthetic Pharmaceutical Simvastatin API Product Offerings

Table 121. Southwest Synthetic Pharmaceutical Recent Developments

Table 122. Krebs Biochemicals & Industries Ltd Company Information

Table 123. Krebs Biochemicals & Industries Ltd Introduction and Business Overview

Table 124. Krebs Biochemicals & Industries Ltd Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 125. Krebs Biochemicals & Industries Ltd Simvastatin API Product Offerings

Table 126. Krebs Biochemicals & Industries Ltd Recent Developments

Table 127. Biocon Company Information

Table 128. Biocon Introduction and Business Overview

Table 129. Biocon Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 130. Biocon Simvastatin API Product Offerings

Table 131. Biocon Recent Developments

Table 132. Zhejiang Jingxin Pharmaceutical Company Information

Table 133. Zhejiang Jingxin Pharmaceutical Introduction and Business Overview

Table 134. Zhejiang Jingxin Pharmaceutical Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 135. Zhejiang Jingxin Pharmaceutical Simvastatin API Product Offerings

Table 136. Zhejiang Jingxin Pharmaceutical Recent Developments

Table 137. Hetero Drugs Company Information

Table 138. Hetero Drugs Introduction and Business Overview

Table 139. Hetero Drugs Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 140. Hetero Drugs Simvastatin API Product Offerings

Table 141. Hetero Drugs Recent Developments

Table 142. DEAFARMA Company Information

Table 143. DEAFARMA Introduction and Business Overview

Table 144. DEAFARMA Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 145. DEAFARMA Simvastatin API Product Offerings

Table 146. DEAFARMA Recent Developments

Table 147. Tecoland Corporation Company Information

Table 148. Tecoland Corporation Introduction and Business Overview

Table 149. Tecoland Corporation Simvastatin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 150. Tecoland Corporation Simvastatin API Product Offerings

Table 151. Tecoland Corporation Recent Developments

Table 152. Key Raw Materials Lists

Table 153. Key Suppliers of Raw Materials Lists

Table 154. Simvastatin API Downstream Customers

Table 155. Simvastatin API Distributors List

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

List of Figures

Figure 1. Simvastatin API Product Picture

Figure 2. Global Simvastatin API Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 4. Global Simvastatin API Sales Volume (Kg), 2021–2032

Figure 5. Global Simvastatin API Sales Price (US$/Kg), 2021–2032

Figure 6. Simvastatin API Report Years Considered

Figure 7. Global Simvastatin API Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Simvastatin API Sales Volume Ranking of Players (Kg), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Simvastatin API Revenue in 2025

Figure 10. Simvastatin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Above 98 % Picture

Figure 12. Above 99 % Picture

Figure 13. Global Simvastatin API Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Simvastatin API Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Simvastatin API Sales Volume by Type (Kg), 2021 vs 2025 vs 2032

Figure 16. Global Simvastatin API Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Simvastatin API Price by Type (US$/Kg), 2021–2032

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Others

Figure 20. Global Simvastatin API Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Simvastatin API Sales Value Market Share by Application, 2025 & 2032

Figure 22. Global Simvastatin API Sales Volume by Application (Kg), 2021 vs 2025 vs 2032

Figure 23. Global Simvastatin API Sales Volume Market Share by Application, 2025 & 2032

Figure 24. Global Simvastatin API Price by Application (US$/Kg), 2021–2032

Figure 25. North America Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 26. North America Simvastatin API Sales Value by Country (%), 2025 vs 2032

Figure 27. Europe Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 28. Europe Simvastatin API Sales Value by Country (%), 2025 vs 2032

Figure 29. Asia Pacific Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 30. Asia Pacific Simvastatin API Sales Value by Region (%), 2025 vs 2032

Figure 31. South America Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 32. South America Simvastatin API Sales Value by Country (%), 2025 vs 2032

Figure 33. Middle East & Africa Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 34. Middle East & Africa Simvastatin API Sales Value by Country (%), 2025 vs 2032

Figure 35. Key Countries/Regions Simvastatin API Sales Value (%), 2021–2032

Figure 36. Key Countries/Regions Simvastatin API Sales Volume (%), 2021–2032

Figure 37. United States Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 38. United States Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 39. United States Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 40. Europe Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 41. Europe Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 42. Europe Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 43. China Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 44. China Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 45. China Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 46. Japan Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 47. Japan Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 48. Japan Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 49. South Korea Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 50. South Korea Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 51. South Korea Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 52. Southeast Asia Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 53. Southeast Asia Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 54. Southeast Asia Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 55. India Simvastatin API Sales Value (US$ Million), 2021–2032

Figure 56. India Simvastatin API Sales Value by Type (%), 2025 vs 2032

Figure 57. India Simvastatin API Sales Value by Application (%), 2025 vs 2032

Figure 58. Simvastatin API Industrial Chain

Figure 59. Simvastatin API Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Simvastatin API market? zhanKai

The top companies in the global Simvastatin API market are Sun Pharma、Teva、Otto Brandes.

Related Reports

Global Simvastatin API Market Research Report 2026
The global Simvastatin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 147
USD 2900.00
(Single User License)
Global Simvastatin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Simvastatin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 108
USD 4250.00
(Single User License)
Global Simvastatin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Simvastatin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 172
USD 4900.00
(Single User License)
Simvastatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Simvastatin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 135
USD 3950.00
(Single User License)
Global Simvastatin API Market Research Report 2025
The global market for Simvastatin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)
Global Simvastatin API Market Research Report 2024
Simvastatin(CAS：79902-63-9) is a statin, a type of lipid-lowering medication.It is used along with exercise, diet, and weight loss to decrease elevated lipid levels.It is also used to decrease the risk of heart problems in those at high risk.
Published Date: 2024-02-07
Pages: 118
USD 2900.00
(Single User License)

Global Simvastatin API Market Research Report 2026
The global Simvastatin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 147
USD 2900.00 (Single User License)
Global Simvastatin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Simvastatin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 108
USD 4250.00 (Single User License)
Global Simvastatin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Simvastatin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 172
USD 4900.00 (Single User License)
Simvastatin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Simvastatin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 135
USD 3950.00 (Single User License)
Global Simvastatin API Market Research Report 2025
The global market for Simvastatin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)
Global Simvastatin API Market Research Report 2024
Simvastatin(CAS：79902-63-9) is a statin, a type of lipid-lowering medication.It is used along with exercise, diet, and weight loss to decrease elevated lipid levels.It is also used to decrease the risk of heart problems in those at high risk.
Published: 2024-02-07
Pages: 118
USD 2900.00 (Single User License)